- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Full Field Digital Mammography May Miss Interval Breast Cancers
Full field digital mammography, performed instead of screen film mammography, finds fewer interval breast cancers.
The switch to full field digital mammography (FFDM) has changed the mammographic presentation of interval breast cancer, with fewer interval cancers presenting in association with microcalcifications, according to a study published in the European Journal of Radiology.
Researchers from Ireland sought to assess the impact of FFDM on the classification of interval breast cancers and to compare the mammographic features of interval cancers at FFDM and screen film mammography (SFM).
The researchers looked at 76 cases of interval breast cancer following FFDM screening and 62 following SFM screening. Five consultant breast radiologists assessed prior screening mammograms. The review classified cases as missed, minimal signs, occult, or true interval breast cancer. Mammographic features of the interval cancer at diagnosis and any abnormality identified on the prior screening mammogram were recorded.
The results showed that there was not much difference between FFDM and SFM for missed cancers, but there were significantly fewer interval cancers presenting as microcalcifications following SFM.
The interval breast cancers did not show up as frequently with FFDM, so this can be problematic, concluded the researchers.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
Mammography-Based AI Abnormality Scoring May Improve Prediction of Invasive Upgrade of DCIS
April 9th 2024Emerging research suggests that an artificial intelligence (AI) score of 75 or greater for mammography abnormalities more than doubles the likelihood of invasive upgrade of ductal carcinoma in situ (DCIS) diagnosed with percutaneous biopsy.
Mammography Study: AI Improves Breast Cancer Detection and Reduces Reading Time with DBT
April 3rd 2024An emerging artificial intelligence (AI) model demonstrated more than 12 percent higher specificity and reduced image reading time by nearly six seconds in comparison to unassisted radiologist interpretation of digital breast tomosynthesis (DBT) images.
